2017-2014 Press Releases


2017

July 25, 2017
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appellate Brief Seeking Reversal of U.S. Patent Board Decision on CRISPR/Cas9 Gene Editing

July 6, 2017
Caribou Biosciences Appoints Steven B. Kanner, Ph.D. as Chief Scientific Officer

May 10, 2017
Caribou Biosciences Announces Grant of a Key CRISPR-Cas9 Genome Editing Patent in Europe

May 2, 2017
Caribou Biosciences Announces Grant of a Key CRISPR-Cas9 Patent in the U.S.

May 1, 2017
Caribou Biosciences and DuPont Pioneer Develop New Method to Comprehensively Map the Off-Target Activity of CRISPR-Cas9 Across Entire Genomes

April 12, 2017
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision

February 15, 2017
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U.K.


2016

December 16, 2016
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology

October 25, 2016
The Jackson Laboratory and Caribou Biosciences Announce CRISPR-Cas9 License Agreement

September 26, 2016
Caribou Biosciences’ President and CEO Rachel Haurwitz Named to Fortune’s 2016 “40 under 40” List of Most Influential Young People in Business

August 30, 2016
Caribou Biosciences Appoints Vonnie Estes as Group Leader, Agricultural and Industrial Biotechnology

August 18, 2016
Caribou Biosciences Develops New Method to Profile CRISPR-Cas9 Gene Editing Outcomes

May 18, 2016
Genus and Caribou Biosciences Announce Exclusive Collaboration for Leading CRISPR-Cas9 Gene Editing Technology in Livestock Species

May 16, 2016
Caribou Biosciences Raises $30 Million in Series B Funding

March 24, 2016
Caribou Biosciences' Co-Founder Dr. Jennifer Doudna and Chairman of the Board Rodolphe Barrangou Selected for 2016 Canada Gairdner Awards

February 23, 2016
Caribou Biosciences and Integrated DNA Technologies (IDT) Announce Non-Exclusive License Agreement for CRISPR-Cas9 Reagents


2015

October 8, 2015
Caribou Biosciences and DuPont announce strategic alliance

April 16, 2015
Caribou Biosciences Co-Founder Dr. Jennifer Doudna Named to TIME Magazine's TIME 100 - TIME's Annual List of the 100 Most Influential People in the World

April 2, 2015
Caribou Biosciences Raises $11 Million in Series A Funding

January 15, 2015
Caribou Biosciences Announces Presentation of New Research Highlighting Progress of its CRISPR-Cas9 Genome Editing Platform

January 7, 2015
Caribou Biosciences Announces New Research Collaboration and Equity Investment Agreements with Novartis


2014

November 18, 2014
Caribou Biosciences Announces Co-Founding of Intellia Therapeutics


 

latest Press Releases